GE HealthCare Technologies Inc. reported third quarter 2025 revenues of $5.1 billion, representing a 6% increase on a reported basis and a 4% rise on an organic basis compared to the prior year. Revenue growth was attributed to performance in the EMEA region and the United States. Total company book-to-bill was 1.06 times, while total company orders increased 6% organically year-over-year. Net income attributable to GE HealthCare was $446 million, down from $470 million in the previous year. Adjusted EBIT for the quarter was $761 million, compared to $795 million a year earlier. Net income margin was 8.7%, down 100 basis points from 9.7%, and Adjusted EBIT margin was 14.8%, down 150 basis points from 16.3%. The margin declines were influenced by tariffs, partially offset by benefits from volume and price.